Australia's largest stock trading and investment forum Australia's #1 stock forum

JAT

Click for more information

4.17%

34.5¢ jatcorp limited

Agree, let the nature take its course, we should leave it to the...

First 101 Last

Share
Profile

Follow
csfoo7721

807 Posts.

213

03/03/19

22:45

Post #: 37637749
Share

Originally posted by Jar-JarBinks: ↑

Even though lactoferrin is widely recognised as an inflammatory modulator, I don't think that a small cap co would take the risk to say it is ok for people with lactose intolerance or any other Inflammatory gastrointestinal diseases. I would prefer that Sunnya/ JAT left it to individuals to work out if it is good for their children and to communicate the beneifts to others. Gastrointestinal problems seem too risky to me. They are often misdiagnosed and problems associated with them are hard to characterise accurately. Also there are a range of levels of severity. A slight improvement may not be viewed favourably by consumers. Increased immunity is a safe target to me and is attractive to a wide audience. In my view it is too risky for a company to make specific claims about lactose intolerance in marketing without testing a specific product in trials . Maybe down the track they could look into it or list some of the benefits that research has identified on their website to increase consumer awareness and so they can consider such benefits as a possibility.

Expand

Agree, let the nature take its course, we should leave it to the experts.

JAT Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

There are more pages in this discussion • 170 more messages in this thread...

First 101 Last

Add JAT (ASX) to my watchlist

(20min delay)
Last 34.5¢		Change -0.015(4.17%)		Mkt cap ! $58.28M

Open	High	Low	Value	Volume
36.5¢	36.5¢	34.5¢	$13.27K	36.83K

Buyers (Bids)

No.	Vol.	Price($)
3	8948	34.0¢

Sellers (Offers)

Price($)	Vol.	No.
35.0¢	9426	1

View Market Depth

No.	Vol.	Price($)
10	1801171	0.056
17	2403917	0.055
3	190000	0.054
2	220000	0.053
1	50000	0.052

Price($)	Vol.	No.
0.057	95645	1
0.058	109100	2
0.059	626122	3
0.060	600000	3
0.061	371000	4

Last trade - 14.36pm 29/11/2024 (20 minute delay)

JAT (ASX) Chart